Selected article for: "ground glass and severe disease"

Author: Ozturk, Saffet; Kurtulus Ozturk, Esin; Yildiz Kaya, Sibel
Title: Clinical and radiological characteristics of COVID‑19 patients without comorbidities: A single-center study
  • Cord-id: 0y5u2kaw
  • Document date: 2021_6_3
  • ID: 0y5u2kaw
    Snippet: OBJECTIVE: To evaluate the clinical characteristics and detailed imaging features in coronavirus disease 2019 (COVID-19) patients without comorbidities. MATERIAL AND METHODS: This retrospective study included laboratory-confirmed and symptomatic COVID-19 patients without comorbid diseases who were admitted to our second level hospital between March 2020 and September 2020. We assessed the clinical, biochemical and imaging diagnostic parameters on admission. The patients were classified as non-se
    Document: OBJECTIVE: To evaluate the clinical characteristics and detailed imaging features in coronavirus disease 2019 (COVID-19) patients without comorbidities. MATERIAL AND METHODS: This retrospective study included laboratory-confirmed and symptomatic COVID-19 patients without comorbid diseases who were admitted to our second level hospital between March 2020 and September 2020. We assessed the clinical, biochemical and imaging diagnostic parameters on admission. The patients were classified as non-severe and progress to severe group and then the initial parameters were compared. RESULTS: We enrolled 135 adult COVID-19 patients, 12 progressed to severe disease during hospitalization. Compared to the non-severe group, patients who progressed to severe were older (p < 0.001) and were more likely to manifest coughing (p = 0.011) and have higher lactate dehydrogenase (LDH) levels (p = 0.011). On chest computed tomography (CT) images, multilobar (p = 0.016), peripherally (p = 0.001) distributed mixed ground glass opacities and consolidation (p < 0.001), crazy paving (p = 0.007) and higher total CT severity score (p < 0.001) were significantly associated with severe disease. CONCLUSION: Knowledge of the clinical and radiological parameters associated with disease severity might be useful to guide clinical decision-making for COVID-19 patients without comorbidities.

    Search related documents:
    Co phrase search for related documents
    • additional disease and low molecular weight heparin: 1, 2
    • additional disease and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • additional disease and lymphocyte count: 1, 2
    • additional disease and lymphocyte neutrophil: 1
    • additional disease and lymphocyte neutrophil ratio: 1
    • additional disease and lymphocyte ratio: 1
    • admission ct severity score and lymphocyte count: 1
    • admission ct severity score and lymphocyte neutrophil: 1, 2, 3
    • admission ct severity score and lymphocyte neutrophil ratio: 1, 2, 3
    • admission ct severity score and lymphocyte ratio: 1, 2, 3
    • liver disease and lobe score: 1
    • liver disease and low lymphocyte count: 1, 2
    • liver disease and low molecular weight heparin: 1, 2, 3
    • liver disease and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver disease and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
    • liver disease and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • liver disease and lymphocyte neutrophil ratio: 1, 2, 3, 4, 5
    • liver disease and lymphocyte ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lobar consolidation and lobe score: 1, 2